Business ❯ Pharmaceuticals

Biopharmaceuticals

Drug Development Manufacturing Biosimilars Product Development Acquisitions Cell-based Therapies Merck KGaA Anticoagulation Therapy Neurology Lifecore Biomedical

JW Pharmaceutical Licenses Korean Rights to Gan & Lee’s GLP-1 Drug in Deal Worth Up to $81 Million

The deal positions JW to start Phase 3 trials in South Korea this year.

GSK to Acquire 35Pharma for $950 Million to Add Pulmonary Hypertension Candidate HS235

AbbVie to Invest $380 Million in Two North Chicago API Plants

Dr Reddy’s Q3 Profit Drops 14% as North America Slows, India Surges and GLP‑1 Rollout Set

Bristol Myers Enters 2026 With Eliquis Medicaid Pact, Opdivo Qvantig Rollout, and Divergent Analyst Views

Okava Launches First GLP-1 Implant Trial for Overweight Cats

Telix Faces Securities Class Action Over Prostate Cancer Disclosures and Supply Chain Claims

Telix Hit With Securities Class Action Over Prostate-Drug Claims and Supply Chain Assurances